17,496 results on '"DIABETES insipidus"'
Search Results
2. Effect of Intranasal Oxytocin on Emotion Recognition and Acute Psycho-Social Stress-induced Cortisol Increase in Patients With Central Diabetes Insipidus and Healthy Controls (OxyMOTION)
3. A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
4. Arginin-stimulated Copeptin in Polyuria-polydipsia Syndrome in Children (COPEPCHILD)
5. Mannitol-induced Release of Copeptin in Healthy Adults and Patients With Polyuria-Polydipsia Syndrome (MARS Study)
6. Wolfram Syndrome and WFS1-related Disorders International Registry and Clinical Study
7. Plasma Copeptin in Response to Oral Urea in Healthy Adults and Patients With Polyuria-polydipsia Syndrome (URANOS)
8. Identifying Oxytocin Deficiency in Adults With Pituitary Disease
9. Low-dose Arginine-vasopressin Supplementation on Post-transplant Acute Kidney Injury After Liver Transplantation (AVENIR Trial)
10. Perioperative Copeptin: Predictive Value and Risk Stratification in Patients Undergoing Major Surgery
11. Baby Detect : Genomic Newborn Screening
12. PB to Treat Hereditary Nephrogenic Diabetes Insipidus, ADPKD Treated With Tolvaptan, and Severely Polyuric Patients With Previous Lithium Administration (SerendipityPB1)
13. Identification and Clinical Relevance of an Oxytocin Deficient State (Melatonin Study)
14. Identification and Clinical Relevance of an Oxytocin Deficient State (GLP1 Study)
15. Identification and Clinical Relevance of an Oxytocin Deficient State (CRH Study)
16. Trans-eyebrow supraorbital keyhole approach for suprasellar and intra-suprasellar Rathke cleft cysts: the experience of 16 cases and a literature review.
17. Paediatric perspectives in the diagnosis of polyuria‐polydipsia syndrome.
18. The phenotypic spectrum of syndromic optic atrophy associated with variants in <italic>WFS1</italic>: with reclassification of p.Val606Gly as a likely benign variant.
19. Real-time intraoperative ultrasound imaging of the posterior pituitary gland during endoscopic endonasal approach.
20. Shortages of Essential Generic Drugs with Limited Competition.
21. Apelin levels in patients with polyuria-polydipsia syndrome upon copeptin stimulation tests.
22. Smartphone Applications for Remote Monitoring of Patients After Transsphenoidal Pituitary Surgery: A Narrative Review of Emerging Technologies.
23. A tale of two pediatric craniopharyngiomas exemplifying treatment strategies.
24. Protocol-Based Standardized Endocrinological Evaluation of Children With Traumatic Brain Injury: A Quality Improvement Initiative.
25. Plasma oxytocin levels in response to glucagon in patients with arginine vasopressin deficiency (central diabetes insipidus) and healthy controls.
26. A case of thyroid storm in a child associated with transient central diabetes insipidus.
27. Decision-making around removal of indwelling urinary catheters after pituitary surgery.
28. Arginine vasopressin deficiency (central diabetes insipidus) with partial empty sella: a case report.
29. Diagnostic Utility of Copeptin in Pediatric Patients with Polyuria-Polydipsia Syndrome: A Systematic Review and Meta-Analysis.
30. Posicionamiento de la deficiencia de arginina-vasopresina central en adultos. Grupo de Trabajo de Neuroendocrinología de la SMNE. Parte 3: tratamiento.
31. Posicionamiento de la deficiencia de arginina-vasopresina central en adultos. Grupo de Trabajo de Neuroendocrinología de la SMNE. Parte 2: cuadro clínico y diagnóstico.
32. Posicionamiento de la deficiencia de arginina-vasopresina central en adultos. Grupo de Trabajo de Neuroendocrinología de la SMNE. Parte 1: definición y etiología.
33. Copeptin after pituitary surgery: is it worth measuring?
34. Ifosfamide-induced nephrogenic diabetes insipidus and Fanconi syndrome in a patient with femur osteosarcoma.
35. Internalizing Symptoms and Their Impact on Patient-Reported Health-Related Quality of Life and Fatigue among Patients with Craniopharyngioma During Proton Radiation Therapy.
36. Effects of glucocorticoid replacement therapy in patients with pituitary disease: A new perspective for personalized replacement therapy.
37. Arginine vasopressin deficiency (central diabetes insipidus) with partial empty sella: a case report
38. AMIloride for the Treatment of Nephrogenic Diabetes Insipidus for Patients With Bipolar Disorder Treated With Lithium (AMIND)
39. Oxytocin Substitution Therapy in Patients With Central Diabetes Insipidus (OxyTUTION)
40. Central diabetes insipidus: A rare primary manifestation of small-cell lung carcinoma
41. Predictive modeling of arginine vasopressin deficiency after transsphenoidal pituitary adenoma resection by using multiple machine learning algorithms
42. Hyponatremia-Induced Epileptic Seizure Provoked by Levetiracetam and Pain Medication Intake in a Patient with Central Diabetes Insipidus
43. Insulin-Induced Copeptin Response in Children and Adolescents to Diagnose Arginine Vasopressin Deficiency.
44. Cognitive function in pituitary adenoma patients: A cross-sectional study.
45. Dexmedetomidine: a real-world safety analysis based on FDA adverse event reporting system database.
46. Acute lymphoblastic leukemia with nephrogenic diabetes insipidus as the first symptom: a case report.
47. Septic Shock, Tubular Necrosis, and Central Diabetes Insipidus: A Challenging Syndrome.
48. Cyclic Adenosine Monophosphate Signaling in Chronic Kidney Disease: Molecular Targets and Therapeutic Potentials.
49. Hypopituitarism, Diabetes Insipidus, and Syndrome of Inappropriate Antidiuretic Hormone Secretion after Pituitary Macroadenoma Surgery with Indocyanine Green Dye.
50. Single Center Neurosurgical Outcomes and Trends in Endoscopic Endonasal Resection of 297 Sellar/Suprasellar Tumors Stratified by Duration of Neurosurgical Career.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.